Listing & Compliance Notices

GRAPHJET TECHNOLOGY received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“June 18, 2025, the Company received a written notice (the “June Notice”) from Nasdaq indicating that the Company no longer complies with Nasdaq Listing Rule 5450(a)(1) (“Rule 5450(a)(1)” and, together with Rule 5550(a)(2), the “Listing Rules”) requiring that listed securities maintain a minimum bid price of $0.10 per share based upon the Company’s closing bid price for the last 10 consecutive trading days prior to the June Notice. The June Notice also stated that the noncompliance with Rule 5450(a)(1) serves as an additional basis for delisting the Company’s securities from Nasdaq, and that th”

GRAPHJET TECHNOLOGY received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 21, 2025, Graphjet Technology (the “Company” or “Graphjet”) received written notice (the “February Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company no longer complied with Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”) requiring that listed securities maintain a minimum bid price of $1.00 per share based upon the Company’s closing bid price for the 32 consecutive days prior to the February Notice. Additionally, the February Notice confirmed that Rule 5550(a)(2) grants the Company 180 calendar days, or until Augus”

SMITH MICRO SOFTWARE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“June 23, 2025, Smith Micro Software, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (“Nasdaq”) indicating that as a result of the closing bid price of the Company’s common stock (“Common Stock”) for the last 30 consecutive business days having been below the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) the Company was not in compliance with the Minimum Bid Price Requirement (the “Minimum Bid Price Notice”). The Minim”

SUPERIOR INDUSTRIES INTERNATIONAL INC received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

“June 17, 2025, Superior Industries International, Inc. (“Superior” or the “Company”) received a written notice from the New York Stock Exchange (the “NYSE”) that the Company no longer satisfies the continued listing compliance standards set forth under Section 802.01C of the NYSE Listed Company Manual (the “Manual”) because the average closing price of the Company’s common stock, par value $0.01 per share (the “Common Stock”) was less than $1.00 per share over a consecutive 30-trading day period (the “Share Price Deficiency Notice”). Pursuant to Section 802.01C of the Manual, the Company has a”

HARVARD BIOSCIENCE INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).

“June 18, 2025, Harvard Biosci e nce, Inc. (the “Company”) notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with the audit committee requirement set forth in Nasdaq Listing Rule 5605(c)(2)(A) (the “Audit Committee Composition Requirement”) due to the Company having only two members on the audit committee (the “Audit Committee”) of its Board of Directors (the “Board”). The Company’s current failure to comply with the Audit Committee Composition Requirement is due to a vacancy resulting from Alan Edrick’s resignation from the Board and the Audit Committee effe”

SHINECO, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“June 16, 2025, Shineco Inc. (the “Company”) received a staff determination letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. Furthermore, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Company is not eligible for any compliance period, since the Company has effected a reverse stock split over the prior one-year period. The Company’s securities will be suspended from”

Nuwellis, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“June 18, 2025, Nuwellis, Inc. (the “Company” ) received a letter (the “Deficiency Notice” ) from the Listing Qualifications Department (the “Staff” ) of the Nasdaq Stock Market ( “Nasdaq” ) informing the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Requirement” ). The Deficiency Notice also indicated th”

Rocky Mountain Chocolate Factory, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).

“June 23, 2025, the Company received a notice from Nasdaq indicating that it had regained compliance with the Rule. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ROCKY MOUNTAIN CHOCOLATE FACTORY, INC. Date: June 23, 2025 By: /s/ Jeffrey R. Geygan Name: Jeffrey R. Geygan Title: Interim Chief Executive Officer”

Sports Entertainment Gaming Global Corp received a nasdaq compliance regained notice regarding minimum bid price (rules 5450(a)(1)).

“June 20, 2025, Lottery.com received a letter from Nasdaq determining that as a result of the Company’s common stock closing at a bid price at or above $1.00 for twenty consecutive business days from May 21 through June 18, 205, the Company has regained compliance with the Bid Price Listing Rule. Nasdaq has closed the matter. Forward Looking Statements This Current Report on Form 8-K (the “Form 8-K”) contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934”

LIPELLA PHARMACEUTICALS INC. received a nasdaq delisting notice notice regarding other (rules 5100, 5635(d), 5640).

“June 17, 2025, indicating that the Panel has determined to delist the Company’s common stock, par value $0.0001 per share (the “Common Stock”), from the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5100, which permits Nasdaq to use its discretionary authority for public interest concerns, due to the Company’s non-compliance with (i) Nasdaq Listing Rule 5635(d), which requires prior shareholder approval for the issuance, other than in a public offering, of 20% or more of a company’s outstanding shares at a per share price less than the Minimum Price (as defined in such rule), and (ii)”

MARIN SOFTWARE INC received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“Delaware corporation (the “Company”), received a notification letter (the “Initial Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”). On May 21, 2025, the Company received an additional notification letter (the “Second Notice”) from Nasdaq advising the Company that it was n”

Unity Biotechnology, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“June 18, 2025, Unity Biotechnology, Inc. (the “Company”) received a notification from The Nasdaq Stock Market (“Nasdaq”) that for the last 30 consecutive business days, the closing bid price of the Company’s common stock was below $1.00 per share, which is the minimum required closing bid price for continued listing on the Nasdaq Global Select Market pursuant to Listing Rule 5450(a)(1). This notice has no immediate effect on the Company’s Nasdaq listing or trading of its common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until December 15”

PHOENIX MOTOR INC. received a nasdaq delisting notice notice regarding other (rules 5250(c)(1), 5550(a)(2), 5620(a)).

“on April 10, 2025 and May 2, 2025, on April 8, 2025 and April 30, 2025, the Company received notices from the Nasdaq Listing Qualifications Department (the “Staff”) stating that the Staff had determined to delist the Company’s securities due to the Company’s non-compliance with Nasdaq Listing Rules 5250(c)(1), 5550(a)(2) and Rule 5620(a), the periodic filing, bid price and shareholder meeting rules, respectively. Trading of the Company’s common stock on Nasdaq was suspended on April 15, 2025. The Company subsequently appealed the Staff’s determination to the Panel at an oral hearing on May 20”

WINDTREE THERAPEUTICS INC /DE/ received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv), 5815(4)(A)).

“June 18, 2025, Windtree Therapeutics, Inc. (the “ Company ”) received a deficiency letter (the “ Bid Price Deficiency Letter ”) from the Nasdaq Listing Qualifications Department (the “ Staff ”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (“ Minimum Bid Price Requirement ”). Normally, a company would be afforded a 180-cal”

AIM ImmunoTech Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“June 17, 2025, AIM ImmunoTech Inc. (the “Company”) received a warning notification (the “Letter”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the minimum stockholders’ equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide (the “Company Guide”) requiring stockholders’ equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years and $6.0 million or more if the Company has reported losses from continuing o”

GRAPHJET TECHNOLOGY received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“June 4, 2025, the Company received a determination letter (the “Determination”) from Nasdaq stating that Nasdaq had determined that the Company did not provide a definitive plan evidencing its ability to achieve compliance with the Listing Rule before July 15, 2025, or 180 days following the due date of the Initial Delinquent Filing. The Determination stated that, as a result, (i) the Company’s request for continued listing on Nasdaq was denied, (ii) the trading of the Company’s Class A Ordinary Shares (the “Common Stock”) will be suspended at the opening of business on June 13, 2025 and (iii)”

Nxu, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 1, 2025, the Company received a letter from the Staff notifying the Company that it had not regained compliance with the Minimum Bid Price Requirement for continued listing on Nasdaq and that, as a result, the Company’s securities would be subject to delisting. Although the Reverse Stock Split had become effective on March 31, 2025, the shares of Class A common stock had not maintained a minimum bid price of $1.00 per share for a minimum of 10 consecutive business days during the applicable compliance period. The Company subsequently appealed the Staff’s determination to Nasdaq’s Hearing”

Laser Photonics Corp received a nasdaq extension granted notice regarding late filing.

“June 13, 2025, Nasdaq notified the Company that it granted the Company’s request to extend the date for the Company to regain compliance with Nasdaq’s Listing Rules to June 20, 2025. A copy of the press release announcing the extended date allowed by Nasdaq for the Company to regain compliance with Nasdaq’s Listing Rules is attached hereto and incorporated herein to this Current Report on Form 8-K as Exhibit 99.1. 99.1 Press Release Issued by Laser Photonics Corporation dated June 16, 2025.”

SUNation Energy, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“June 10, 2025, the Company received the Nasdaq Hearing Panel’s decision in which it notified the Company that it did not find the Company to be in violation of Listing Rules 5100 and 5550(a)(2), the “Public Interest Concern” and “Bid Price Rule”, respectively. Accordingly, the June 10, 2025 letter further provided that the Company is deemed to be in full compliance with the applicable Nasdaq Listing Rules, and that the above-referenced matter was closed.”

CarParts.com, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“June 13, 2025, CarParts.com, Inc. (the “Company”), received a letter from the Listing Qualifications Department of The NASDAQ Stock Market, LLC (“Nasdaq”) notifying the Company that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Rule”), as the minimum bid price for the Company’s listed securities was less than $1 for the previous 30 consecutive business days. The Company has a period of 180 calendar days, or until December 10, 2025 (the “Compliance Date”), to regain compliance with the Bid Price Rule. To regain compliance, the bid price of the Company’s c”

RYVYL Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“June 12, 2025, RYVYL Inc., a Nevada corporation (the “Company”), received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that, because the closing bid price for its common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Nasdaq Lising Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). Nasdaq’s notice has no immediate effect on the listing of the Company’s common stock on th”

AMERICAN REBEL HOLDINGS INC received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“June 11, 2025, the Company received a letter from Nasdaq accepting the Compliance Plan and granting an extension through August 18, 2025 to evidence compliance with the Rule. In the event the Company fails to evidence compliance within the extension period, the Company will have the right to a hearing before Nasdaq’s Hearing Panel. The hearing request would stay any suspension or delisting action pending the conclusion of the hearing process and the expiration of any additional extension period granted by the panel following the hearing.”

Equillium, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 13, 2024, Equillium, Inc. (the “ Company ” ) received a notice from The Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of the Company’s common stock had been below $1.00 per share for the previous 30 consecutive business days (the “ Minimum Bid Price Requirement ”). The Company was given 180 days, or until June 11, 2025, to regain compliance with the Minimum Bid Price Requirement. On June 12, 2025, the Company received a notice from Nasdaq that the Company was granted an additional 180 calen”

Breeze Holdings Acquisition Corp. received a otc deficiency notice notice regarding other.

“March 17, 2025, Breeze Holdings Acquisition Corp. (the “Company”) was notified by OTC Markets Group Inc. that, as of such date, its publicly traded warrants (BRZHW) and publicly traded rights (BRZHR) no longer satisfy the continued qualification requirements for the OTCQX Market, as set forth in Section 2 of the Requirements for Continued Qualification of the OTCQX Rules for U.S. Companies, which requires compliance with Section 1.1(A) of the OTCQX Eligibility Criteria, requiring the Company to have (1) net tangible assets of $2,000,000, if the Company has been in continuous operation for at l”

Dragonfly Energy Holdings Corp. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2), 5810(d), 5550(a)(2)).

“June 11, 2025, Dragonfly Energy Holdings Corp. (the “Company”) received an additional staff determination letter (the “MVLS Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the Company’s non-compliance with Nasdaq Listing Rule 5550(b)(2), which requires the Company to maintain a minimum Market Value of Listed Securities (“MVLS”) of $35 million for continued listing on The Nasdaq Capital Market (the “MVLS Requirement”) for the 30 consecutive business days preceding receipt of the MVLS Letter, the Staff has determi”

CERO THERAPEUTICS HOLDINGS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“June 11, 2025, CERo Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), received a letter (the “Bid Price Requirement Letter”) from the Listing Qualifications Department (the “Staff”) at The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the 30 consecutive business day period between April 25, 2025 through June 9, 2025, the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(”

OLENOX INDUSTRIES INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“June 11, 2025, Safe & Green Holdings Corp. (the “Company”) was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s continued non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as of June 10, 2025, the deficiency could serve as an additional basis for the delisting of the Company’s securities from Nasdaq. The Company plans to present its plan to regain compliance with the Rule at its upcoming hearing before the Nasdaq Hearings Panel. The notice no immediate ef”

Boxlight Corp received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(b)(1)).

“sfer of Listing. As previously reported in the Company’s Current Report on Form 8-K filed on June 4, 2025, R. Wayne Jackson resigned as a director of the Company on May 23, 2025. Also as previously reported, as a result of Mr. Jackson’s resignation, the Company is not in compliance with Nasdaq Rule 5605(c)(2)(A), which requires, among other things, that audit committees have at least three members and that at least one member have past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which resul”

Lulu's Fashion Lounge Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price.

“February 27, 2025, the Company received a letter from Nasdaq indicating that the Company was not in compliance with the minimum close bid price of $1.00 per share required for continued listing. The Company has 180 calendar days, or until August 26, 2025, to regain compliance with the minimum bid price rule. As part of the Approval, the Company will be afforded the remainder of this compliance period to comply with the minimum bid price requirement. As discussed below, at the Company’s Annual Meeting of Stockholders held on June 10, 2025 (the “Annual Meeting”), the Company’s stockholders appro”

Lulu's Fashion Lounge Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).

“quirements. ​ As previously disclosed, on May 21, 2025, the Company received a letter from Nasdaq indicating that the Company was not in compliance with the minimum of $10 million of stockholders’ equity required for continued listing on the Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(1)(A), because the Company’s stockholders’ equity as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 30, 2025 was approximately $6.6 million. In response, the Company filed an application to transfer the listing of its Common Stock from the Nasdaq Global Ma”

AIM ImmunoTech Inc. received a nyse_american compliance regained notice regarding minimum bid price (rules 1003(f)(v)).

“June 11, 2025, AIM ImmunoTech Inc. (the “Company”) was notified by The NYSE American (the “Exchange”) that the Company has regained compliance with Section 1003(f)(v) of the NYSE American Company Guide (low selling price) and that trading in the Company’s Common Stock is expected to be reinstated on the Exchange on June 17, 2025 and the ticker symbol will be “AIM” upon reinstatement. The Company’s Common Stock currently trades on the OTC Pink under the symbol “AIMID”. The new CUSIP is 00901B303.”

Axe Compute Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“June 9, 2025, Predictive Oncology Inc. (the “Company”) received a letter (the “Notice) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that because the Company had not regained compliance with the minimum $2,500,000 stockholders’ equity requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”), the Staff has determined to delist the Company’s securities from The Nasdaq Capital Market. The Company was unable to complete its previou”

IGM Biosciences, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“June 6, 2025, IGM Biosciences, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is no longer in compliance with the minimum Market Value of Listed Securities (“MVLS”) of $50,000,000 required for continued listing on The Nasdaq Global Select Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”). The Notice has no effect at this time on the listing of the Company’s common stock (the “Common Stock”), which continues to trade on The Nasdaq Global Select Market under the symbol “IGMS”. In”

Sunnova Energy International Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

“June 9, 2025, the Company received written notice (the “Delisting Notice”) from the staff of NYSE Regulation of the New York Stock Exchange (the “NYSE”) notifying the Company that, as a result of the Chapter 11 Cases and in accordance with Section 802.01D of the NYSE Listed Company Manual, the NYSE had determined to commence proceedings to delist the Company’s common stock, par value $0.0001 per share (the “common stock”), and that trading in the common stock was suspended immediately. The NYSE will apply to the U.S. Securities and Exchange Commission (the “Commission”) to delist the common st”

GRAPHJET TECHNOLOGY received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“June 4, 2025, the Company received a determination letter (the “Determination”) from Nasdaq stating that Nasdaq had determined that the Company did not provide a definitive plan evidencing its ability to achieve compliance with the Listing Rule before July 15, 2025, or 180 days following the due date of the Initial Delinquent Filing. The Determination stated that, as a result, (i) the Company’s request for continued listing on Nasdaq was denied, (ii) the trading of the Company’s Class A Ordinary Shares (the “Common Stock”) will be suspended at the opening of business on June 13, 2025 and (iii)”

Australian Oilseeds Holdings Ltd received a nasdaq delisting notice notice regarding stockholders equity (rules 5450(b)(1)).

“June 4, 2025, Australian Oilseeds Holdings Limited (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it has not regained compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Global Market. Nasdaq Listing Rule 5450(b)(1) requires listed companies to maintain stockholders’ equity of at least $10,000,000 (the “Stockholders’ Equity Requirement”). As previously noted in the Company’s Current Report on Form 8-K filed with the SEC on December 12, 2024, the Company receive”

CEMTREX INC received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“June 4, 2025, the Company received a letter from Nasdaq notifying the Company that based on the Company’s Form 10-Q for the period ended March 31, 2025, filed on May 15, 2025, evidencing stockholders’ equity of $6,403,022, Nasdaq has determined that the Company complies with the Minimum Stockholder’s Equity Requirement and this matter is now closed.”

Genprex, Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1), 5550(b)(2), 5550(b)(3)).

“June 6, 2025, Genprex, Inc. (the “Company”) received a letter (the “June 2025 Compliance Letter”) from the Listing Qualifications Department (the “Nasdaq Staff”) of The Nasdaq Stock Market (“Nasdaq”) providing written confirmation that the Company has regained compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”). The June 2025 Compliance Letter was pursuant to a previous letter received on November 19, 2024 (the “November 2024 Notice”) from the Nasd”

AMERICAN VANGUARD CORP received a nyse noncompliance notice notice regarding late filing (rules 802.01E).

“June 6, 2025, the Company received written notice from NYSE Regulation closing this matter and confirming that the Company had regained compliance with Section 802.01E of the NYSE Listed Company Manual. The notice followed the Company filing the Form 10-K and its Form 10-Q for the fiscal quarter ended March 31, 2025.”

PLUS THERAPEUTICS, INC. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

“June 3, 2025, Plus Therapeutics, Inc. (the “Company”) received a letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company had regained compliance with the Rule 5250(c)(1) due to filing its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Quarterly Report”) with the U.S. Securities and Exchange Commission (the “SEC”) on May 30, 2025. As previously disclosed, on March 8, 2024, the Company received a written notice from the Staff, notifying the Company that it no longer complied with the requir”

Orgenesis Inc. received a otc delisting notice notice regarding late filing.

“June 2, 2025, the OTC Markets Group (“OTC Markets”) notified Orgenesis Inc. (the “Company”) that it has determined to move the Company’s common stock from OTCQX to the Pink Limited tier effective June 3, 2025. As previously reported, On April 17, 2025, Orgenesis Inc. (the “Company”) received a notice that is delinquent in filing its 10-K for the period ending December 31 st , 2024 and therefore no longer meets the OTCQX Requirements for Continued Qualification as per Section 2.2 (A)(1)(i) of the OTCQX Rules for U.S. Companies: All required annual, quarterly and other interim reports on EDGAR.”

BRC Group Holdings, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“June 4, 2025, B. Riley Financial, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that, as a result of the Company’s delay in filing its Annual Report on Form 10-K for the period ended December 31, 2024 and its Quarterly Report on Form 10-Q for the period ended March 31, 2025, the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”). The Notice stat”

INTENSITY THERAPEUTICS, INC. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“June 6, 2025, Intensity Therapeutics, Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The notice has no immediate effect on the listing or trading of the Company’s common stock, and the common stock will continue to trade on The Nasdaq Capital Market under the symbol “INTS” at this time. In accordance with Nasdaq List”

High Roller Technologies, Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(ii)).

“June 4, 2025, High Roller Technologies, Inc. (the “Company”) was notified by NYSE American LLC that due to reporting of stockholders’ equity of approximately $2.8 million, the Company no longer meets the requirement that it must have no less than $4 million or more in stockholders’ equity pursuant to the continued listing standards set forth under Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) because the Company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years ended December 31, 2024 and the Company do”

BNB PLUS CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(A)(iv)).

“May 30, 2025 (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company no longer satisfies the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of thirty (30) consecutive business days (colle”

TALPHERA, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5450(a)(1), 5810(c)(3)(A), 5810(c)(3)(A)(ii)).

“June 5, 2025, Talphera, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) granting the Company an additional 180 days, until December 1, 2025 (the “Second Compliance Period”), to regain compliance with the $1.00 bid price requirement, as set forth in Nasdaq Listing Rule 5550(a)(2). To regain compliance with such minimum price requirement, the Company must evidence a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. As previously announced, on December”

iSpecimen Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“June 4, 2025, iSpecimen Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders’ equity for continued listing on the Nasdaq Capital Market. As reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2025, the Company had stockholders’ equity of $1,668,513. Nasdaq further noted that the Company does not currently meet the alternative continued listing crite”

ARTESIAN RESOURCES CORP received a nasdaq deficiency notice notice regarding other (rules 5605(b)(1), 5605(c)(2), 5605(a)(2), 5605(c)(4)).

“May 30, 2025, Artesian Resources Corporation (the “Company”) received a written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is no longer in compliance with Nasdaq Marketplace Rule 5605(b)(1), which requires that a majority of the Company’s Board of Directors (the “Board”) be “independent directors” as defined in Nasdaq Marketplace Rule 5605(a)(2) (the “Majority Independent Board Requirement”) and Nasdaq Marketplace Rule 5605(c)(2), which requires the Company to have an audit committee composed of at least three “independent directors” as defi”

SUPERIOR INDUSTRIES INTERNATIONAL INC received a nyse deficiency notice notice regarding market value (rules 802.01B).

“June 2, 2025, Superior Industries International, Inc. (“Superior” or the “Company”) received a written notice (the “Notice”) from the New York Stock Exchange (“NYSE”) that the Company did not presently satisfy NYSE’s continued listing standards under Section 802.01B of the NYSE Listed Company Manual (the “Manual”), which requires the Company’s 30-trading day average market capitalization to be not less than $50 million and the Company’s stockholders’ equity to be not less than $50 million. As set forth in the Notice, as of May 30, 2025, the Company’s 30-trading day average market capitalizatio”

Reborn Coffee, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“May 29, 2025, Reborn Coffee, Inc., a Delaware corporation (the “Company”) received a notification letter (the “Letter”) from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that its stockholders’ equity had fallen below the $2,500,000 required minimum for continued listing set forth in Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”). The Company’s stockholders’ equity was $415,582 as of March 31, 2025, as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2025. The Letter also noted that as of May 29”